Tonsillectomy Improved Therapeutic Response in Anti-SRP Myopathy With Chronic Tonsillitis.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 16 08 2020
accepted: 28 10 2020
entrez: 17 12 2020
pubmed: 18 12 2020
medline: 10 7 2021
Statut: epublish

Résumé

Chronic tonsillitis has been attracted attention as a source of abnormal immune responses and a possible trigger of autoimmune diseases such as IgA nephritis, IgA vasculitis, palmoplantar pustulosis, psoriasis, rheumatoid arthritis, Behçet's disease, and myositis. Here we present the first report of anti-signal recognition particle antibody-associated necrotizing myopathy (anti-SRP myopathy) with IgA nephropathy and chronic tonsillitis in which the therapeutic response to intravenous immunoglobulin (IVIG) treatment was dramatically improved after tonsillectomy and accompanied by a rapid increase in ΔIgG, defined as the change in serum IgG levels 2 weeks after the start of IVIG treatment relative to pre-treatment levels. Moreover, serum anti-SRP antibody titers became undetectable after tonsillectomy even though the resected tonsils did not produce anti-SRP antibodies. Tonsillectomy should be considered when chronic tonsillitis is observed in patients with autoimmune diseases showing poor response to treatment, including anti-SRP myopathy.

Identifiants

pubmed: 33329585
doi: 10.3389/fimmu.2020.595480
pmc: PMC7732549
doi:

Substances chimiques

Immunoglobulins, Intravenous 0
Signal Recognition Particle 0

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

595480

Informations de copyright

Copyright © 2020 Ikeda, Takeuchi, Takahashi, Nakamura, Kunii, Katsumoto, Tada, Higashiyama, Hibiya, Suzuki, Nishino, Koyano, Doi and Tanaka.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Orphanet J Rare Dis. 2015 May 13;10:61
pubmed: 25963141
J Nephrol. 2016 Feb;29(1):13-9
pubmed: 26582216
Neuromuscul Disord. 2018 Jan;28(1):87-99
pubmed: 29221629
Nat Med. 2019 Dec;25(12):1822-1832
pubmed: 31806905
Ann Neurol. 2009 Nov;66(5):597-603
pubmed: 19938102
Am J Kidney Dis. 2015 Jan;65(1):80-7
pubmed: 25446024
Kidney Int. 2004 Apr;65(4):1135-44
pubmed: 15086452
Nat Rev Nephrol. 2012 Mar 20;8(5):275-83
pubmed: 22430056
Immun Inflamm Dis. 2019 Jun;7(2):86-93
pubmed: 30957421
Acta Otolaryngol Suppl. 1993;508:36-42
pubmed: 8285041
Nephron. 1996;74(2):301-8
pubmed: 8893145
Nephrol Dial Transplant. 2013 Dec;28(12):3004-13
pubmed: 24081865

Auteurs

Takuya Ikeda (T)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Hideyuki Takeuchi (H)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Keita Takahashi (K)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Haruko Nakamura (H)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Misako Kunii (M)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Atsuko Katsumoto (A)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Mikiko Tada (M)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Yuichi Higashiyama (Y)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Takashi Hibiya (T)

Department of Pathology, Yokohama City University Hospital, Yokohama, Japan.

Shigeaki Suzuki (S)

Department of Neurology, Keio University School of Medicine, Tokyo, Japan.

Ichizo Nishino (I)

Department of Neuromuscular Research, National Institute of Neuroscience, and Department of Genome Medicine Development, Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan.

Shigeru Koyano (S)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Hiroshi Doi (H)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Fumiaki Tanaka (F)

Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH